{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answer.questionFirstAnswered.=2017-04-27T08%3A39%3A39.29Z&answeringDeptId=203&max-answer.questionFirstAnswered.=2017-04-27T09%3A22%3A25.27Z", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?answer.questionFirstAnswered.=2017-04-27T08%3A39%3A39.29Z&answeringDeptId=203&max-answer.questionFirstAnswered.=2017-04-27T09%3A22%3A25.27Z", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answer.questionFirstAnswered.=2017-04-27T08%3A39%3A39.29Z&answeringDeptId=203&_metadata=all&max-answer.questionFirstAnswered.=2017-04-27T09%3A22%3A25.27Z", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answer.questionFirstAnswered.=2017-04-27T08%3A39%3A39.29Z&_page=0&answeringDeptId=203&max-answer.questionFirstAnswered.=2017-04-27T09%3A22%3A25.27Z", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answer.questionFirstAnswered.=2017-04-27T08%3A39%3A39.29Z&answeringDeptId=203&max-answer.questionFirstAnswered.=2017-04-27T09%3A22%3A25.27Z", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answer.questionFirstAnswered.=2017-04-27T08%3A39%3A39.29Z&answeringDeptId=203&max-answer.questionFirstAnswered.=2017-04-27T09%3A22%3A25.27Z", "items" : [{"_about" : "http://data.parliament.uk/resources/724245", "AnsweringBody" : [{"_value" : "Department for Exiting the European Union"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/724245/answer", "answerText" : {"_value" : "<p>The Government is committed to ensuring a positive outcome for the UK life sciences and pharmaceuticals sector as we exit the European Union.<\/p><p>In the negotiations, the Government will discuss with the EU and Member States how best to continue to cooperate in the field of medicines regulation in the best interests of both the UK and EU. It would not be appropriate to pre-judge the outcome of the negotiations.<\/p><p> <\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4091", "label" : {"_value" : "Biography information for Mr Robin Walker"}
        }
        , "answeringMemberConstituency" : {"_value" : "Worcester"}
        , "answeringMemberPrinted" : {"_value" : "Mr Robin Walker"}
        , "dateOfAnswer" : {"_value" : "2017-04-27", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : [{"_value" : "71886"}
        , {"_value" : "71899"}
        ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2017-04-27T08:39:39.29Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "203"}
      , "answeringDeptShortName" : {"_value" : "Exiting the European Union"}
      , "answeringDeptSortName" : {"_value" : "Exiting the European Union"}
      , "date" : {"_value" : "2017-04-25", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Drugs: Manufacturing Industries"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Exiting the European Union, what the Government's objectives are for regulation for pharmaceuticals after the UK leaves the EU.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1484", "label" : {"_value" : "Biography information for Helen Goodman"}
      }
      , "tablingMemberConstituency" : {"_value" : "Bishop Auckland"}
      , "tablingMemberPrinted" : [{"_value" : "Helen Goodman"}
      ], "uin" : "71898"}
    ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 1, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}